港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

長風藥業

32.320

+1.8205.97%

成交量：42.44萬

成交額：1,354.85萬

市值：133.15億

市盈率：519.70

高：32.500

開：31.000

低：30.880

收：30.500

52周最高：48.800

52周最低：27.200

股本：4.12億

香港流通股本：3.02億

量比：1.84

換手率：0.14%

股息：- -

股息率：- -

每股收益(LYR):0.062

淨資產收益率：-5.62%

總資產收益率：-5.30%

市淨率：12.70

市盈率(LYR):519.71

市銷率: 20.16

資料載入中...

總覽公司新聞資訊公告

長風藥業上市首日股價漲超200%：新一輪狂歡的密碼在「創新」二字？

医药研究社

超5000倍認購，長風藥業為何成為「人氣王」？

CPHI制药在线

開盤翻倍，市值飆破150億！蘇州「博士搭檔」如何煉就港股新貴？

上市首日開盤暴漲隨即回落，長風藥業超額認購背後有何隱憂？

21世纪经济报道

交銀國際助力長風藥業完成香港IPO項目

異動解讀 | 長風藥業上市次日大跌5.45%，或因投資者獲利了結

異動解讀 | 長風藥業盤中大跌5.45%，或因上市首日暴漲後的獲利回吐

異動解讀 | 長風藥業上市首日表現強勁，盤中大漲5.04%

中信證券保薦國產吸入製劑龍頭企業長風藥業登陸港交所

中信证券发布

歡迎長風藥業股份有限公司 (HK.2652) 今日在港上市！

諾獎點燃創新藥板塊新股長風藥業暴漲1.6倍

上市首日大漲218%，長風藥業單品依賴症未解

200億，中國藥谷又跑出一個IPO

開盤暴漲225%！長風藥業正式登陸港交所，吸入製劑龍頭，國產替代疊加需求爆發

独角兽早知道

勇敢者遊戲：超5000倍認購的藥企IPO

生物制药小编

好買股權母基金被投企業「長風藥業」上市

招銀國際作為聯席保薦人兼整體協調人、聯席全球協調人助力長風藥業股份有限公司（長風藥業）在香港聯交所主板完成上市

異動解讀 | 長風藥業上市首日盤中大漲218.64%，超高認購率反映市場熱捧

異動解讀 | 長風藥業上市首日股價暴漲218.64%，吸入技術龍頭備受追捧

新股首日｜長風藥業首掛高開逾218%，中籤一手賺超16000港元

老虎资讯综合

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02652/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"長風藥業","latestPrice":32.32,"timestamp":1763366893787,"preClose":30.5,"halted":0,"volume":424400,"delay":0,"floatShares":302223586,"shares":411978387,"eps":0.0621893725523728,"marketStatus":"未開盤","change":1.82,"latestTime":"11-17 16:08:13","open":31,"high":32.5,"low":30.88,"amount":13548498,"amplitude":0.053115,"askPrice":32.4,"askSize":4500,"bidPrice":32.32,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":0.08183882616502777,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1763429400000},"marketStatusCode":0,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":30.5,"openAndCloseTimeList":[[1763343000000,1763352000000],[1763355600000,1763366400000]],"volumeRatio":1.83564,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":302223586,"roa":"-5.30%","roe":"-5.62%","lyrEps":0.062189,"volumeRatio":1.83564,"shares":411978387,"dividePrice":0,"high":32.5,"amplitude":0.053115,"preClose":30.5,"low":30.88,"week52Low":27.2,"pbRate":"12.70","psRate":"20.16","week52High":48.8,"institutionHeld":0,"latestPrice":32.32,"committee":-0.636364,"eps":0.0621893725523728,"divideRate":0,"volume":424400,"delay":0,"ttmEps":0.08183882616502777,"open":31,"prevYearClose":14.75,"prevWeekClose":30.5,"prevMonthClose":30.3,"prevQuarterClose":14.75,"fiveDayClose":29,"twentyDayClose":29.46,"sixtyDayClose":14.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2025-11-14","current":394.967687,"percent":0.884615,"low":-293.764894,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"high":450.433063,"avg":375.248585,"sd":132.0415,"marketCap":12565340803},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106},{"date":"2025-10-31","current":411.638127,"twenty":385.87135,"median":395.798507,"eighty":410.009732,"marketCap":12482945126},{"date":"2025-11-07","current":380.629431,"twenty":385.87135,"median":397.412529,"eighty":410.009732,"marketCap":11535394836},{"date":"2025-11-14","current":413.442652,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"marketCap":12565340803}],"updateTime":1763378658945},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2574168065","title":"長風藥業上市首日股價漲超200%：新一輪狂歡的密碼在「創新」二字？","url":"https://stock-news.laohu8.com/highlight/detail?id=2574168065","media":"医药研究社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574168065?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 20:26","pubTimestamp":1760012784,"startTime":"0","endTime":"0","summary":"来源｜医药研究社“由A转港”这步棋，长风药业算走对了。据悉，长风药业曾于2021年2月和2023年6月两度向上交所科创板递交上市申请，而后于2024年6月撤回A股上市计划，随后在2024年11月、2025年6月先后两次向港交所递交招股书，中信证券、招银国际联席保荐。就在国庆假期最后一天，长风药业也终于成功登陆港交所，首日开盘价为48港元/股，大涨超200%，市值逼近200亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009212800a4585eb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009212800a4585eb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":1},{"id":"2574151638","title":"超5000倍認購，長風藥業為何成為「人氣王」？","url":"https://stock-news.laohu8.com/highlight/detail?id=2574151638","media":"CPHI制药在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574151638?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 17:57","pubTimestamp":1760003846,"startTime":"0","endTime":"0","summary":"关注并星标CPHI制药在线10月8日，长风药业正式在港交所上市，股价一度涨超220%。在本次IPO中，长风药业计划发行约4119.8万股H股，每股14.75港元。从认购情况看，其获得5587倍的超额认购，超过了此前银诺医药的5341倍，成为港交所上市药企中的人气王。已上市药物，对标全球畅销药目前，长风药业在国内已有两款商业化产品。依靠已上市产品的商业化，长风药业成为港股新上市药企中为数不多的净利润为正的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009193731a45840a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009193731a45840a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":1},{"id":"2574158632","title":"開盤翻倍，市值飆破150億！蘇州「博士搭檔」如何煉就港股新貴？","url":"https://stock-news.laohu8.com/highlight/detail?id=2574158632","media":"苏商会","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574158632?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 17:06","pubTimestamp":1760000776,"startTime":"0","endTime":"0","summary":"长风药业港股上市，市值破150亿10月8日，长风药业成功于香港交易所主板挂牌上市。长风药业此次全球发售共4119.8万股，发行价为每股14.75港元，募集资金净额约5.25亿港元。资本市场对长风药业的关注度在上市首日充分显现。长风药业当日股价大幅高开，盘中最高涨幅超过200%。截至收盘，股价报38.50港元，较发行价上涨161.02%，总市值约158.61亿港元，展现出投资者对其技术实力与发展前景的认可。今年1至7月，苏州规上外资生物医药企业产值已超880亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009171412a4581be8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009171412a4581be8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652","HSTECH"],"gpt_icon":1},{"id":"2574776182","title":"上市首日開盤暴漲隨即回落，長風藥業超額認購背後有何隱憂？","url":"https://stock-news.laohu8.com/highlight/detail?id=2574776182","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574776182?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 13:07","pubTimestamp":1759986420,"startTime":"0","endTime":"0","summary":"　　国内吸入制剂市场长期被跨国药企垄断，长风药业用十八年时间成功撬开了一道裂缝。　　10月8日，长风药业股份有限公司正式在港交所主板挂牌交易。10月9日，长风药业小幅高开后回落，截至午间收盘报34.44港元/股。　　根据港交所公布的信息，长风药业香港公开发售部分获得了近6700倍的超额认购，这一数字在今年的港股IPO市场中名列前茅。　　高涨的市场热情背后，是投资者对长风药业所处赛道的看好。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-10-09/doc-infthnhq0749778.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-10-09/doc-infthnhq0749778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02652"],"gpt_icon":1},{"id":"2574819731","title":"交銀國際助力長風藥業完成香港IPO項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2574819731","media":"交银国际","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574819731?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 12:29","pubTimestamp":1759984167,"startTime":"0","endTime":"0","summary":"企业融资业务10月8日，长风药业股份有限公司在香港联交所主板挂牌上市。长风药业本次全球发售定价每股14.75港元，发行41,198,000股，融资规模约为6.08亿港元。交银国际担任联席账簿管理人兼联席牵头经办人，助力长风药业成功登陆港股市场。长风药业是一家专注于吸入技术与吸入药物研发、生产及商业化的创新药企，致力于呼吸系统疾病的治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009123215a6b1729a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009123215a6b1729a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1147","02652","03329"],"gpt_icon":0},{"id":"1178797833","title":"異動解讀 | 長風藥業上市次日大跌5.45%，或因投資者獲利了結","url":"https://stock-news.laohu8.com/highlight/detail?id=1178797833","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178797833?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 10:06","pubTimestamp":1759975586,"startTime":"0","endTime":"0","summary":"刚刚在港交所上市的长风药业今日盘中大跌5.45%，引发市场关注。这一跌幅与其昨日上市首日161.02%的涨幅形成鲜明对比。长风药业于10月8日在港交所主板挂牌上市，首日收盘价为38.50港元，较14.75港元的发行价大涨161.02%。分析人士指出，今日的大幅下跌很可能是由于投资者在昨日强劲涨幅后选择获利了结。尽管如此，长风药业作为呼吸系统药物研发领域的重要参与者，其长期发展前景仍值得关注。投资者应密切关注公司未来的研发进展和市场表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02652"],"gpt_icon":0},{"id":"1178259083","title":"異動解讀 | 長風藥業盤中大跌5.45%，或因上市首日暴漲後的獲利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1178259083","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178259083?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 10:06","pubTimestamp":1759975584,"startTime":"0","endTime":"0","summary":"长风药业（02652.HK）今日盘中大跌5.45%，引发市场关注。该公司刚于10月8日在港交所主板挂牌上市，上市首日股价大涨161.02%，收于38.50港元。\n\n分析人士认为，今日的下跌可能是上市首日暴涨后的正常调整。长风药业上市时发行价为14.75港元，募集资金净额约5.25亿港元。公司计划将募集资金用于国内外吸入制剂候选产品的研发、临床开发，以及生产设施扩张等方面。\n\n长风药业专注于呼吸系统吸入制剂的研发，产品线覆盖哮喘、慢性阻塞性肺病及过敏性鼻炎等高需求领域。尽管今日股价回调，但投资者仍普遍看好公司的长期发展前景。市场将继续关注公司后续的研发进展及业绩表现。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02652"],"gpt_icon":0},{"id":"1106945218","title":"異動解讀 | 長風藥業上市首日表現強勁，盤中大漲5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=1106945218","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106945218?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 09:32","pubTimestamp":1759973545,"startTime":"0","endTime":"0","summary":"长风药业今日盘中大涨5.04%，延续上市首日的强劲势头。该公司于10月8日在港交所主板挂牌上市，首日股价就大幅上涨161.02%，显示出市场对这家专注于呼吸系统吸入制剂研发的企业的高度认可。长风药业此次全球发售4119.8万股H股，发行价为每股14.75港元，共募集资金净额约5.25亿港元。分析人士认为，长风药业的产品线覆盖哮喘、慢性阻塞性肺病及过敏性鼻炎等高需求领域，且具备四大技术平台，在吸入制剂领域具有较强竞争力。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02652"],"gpt_icon":0},{"id":"2573892571","title":"中信證券保薦國產吸入製劑龍頭企業長風藥業登陸港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2573892571","media":"中信证券发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573892571?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 20:51","pubTimestamp":1759927892,"startTime":"0","endTime":"0","summary":"2025年10月8日，长风药业股份有限公司成功于香港联交所主板上市，发行规模约6.08亿港币。中信证券担任牵头保荐人、整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人。中信证券根据长风药业的发展阶段和市场变化，为企业提供最优资本市场解决方案，在本次上市发行过程中牵头完成各项工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008205347a6b0c53c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"817803f49aa9435c21f99f0f245d4c72","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008205347a6b0c53c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652","BK1516","LU1720050803.USD","BK1521","LU1794554557.SGD","BK1564","06030","BK1147"],"gpt_icon":1},{"id":"2574907207","title":"歡迎長風藥業股份有限公司 (HK.2652) 今日在港上市！","url":"https://stock-news.laohu8.com/highlight/detail?id=2574907207","media":"市场资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574907207?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 18:18","pubTimestamp":1759918680,"startTime":"0","endTime":"0","summary":"（来源：香港交易所脉搏/HKEx Pulse）欢迎长风药业股份有限公司 (HK.2652) 今日在港上市！\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkzmt/2025-10-08/doc-inftfzsq9689588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02652"],"gpt_icon":0},{"id":"2573943991","title":"諾獎點燃創新藥板塊 新股長風藥業暴漲1.6倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2573943991","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573943991?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 15:53","pubTimestamp":1759909998,"startTime":"0","endTime":"0","summary":"金吾财讯 | 新股长风药业 涨势强劲，现价报38.34港元，涨幅159.93%。而创新药板块部分走强，维亚生物涨12.2%，复宏汉霖涨11.08%，歌礼制药-B、信达生物、三生制药及中国生物制药分别跟涨5.88%、3.98%、3.41%及2.53%。市场分析认为，该板块涨势或与2025年诺贝尔生理学或医学奖结果揭晓有关。有观点指出，此次诺奖有望进一步推动Treg细胞治疗及相关创新药领域的研发热情与市场关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008155959a6b08a0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"aad3debf34e59353425f33727c1c39c4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008155959a6b08a0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1574","02652","BK1161"],"gpt_icon":0},{"id":"2573910323","title":"上市首日大漲218%，長風藥業單品依賴症未解","url":"https://stock-news.laohu8.com/highlight/detail?id=2573910323","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573910323?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 14:35","pubTimestamp":1759905330,"startTime":"0","endTime":"0","summary":"历经两次上市折戟，长风药业于10月8日终登港交所，开盘涨幅达218.64%，迎来“开门红”。然而，亮眼表现背后隐患犹存：长风药业业绩高度依赖单一产品“吸入用布地奈德混悬液”，该产品收入占比连续多年超过90%，且正面临市场竞争加剧与增长乏力的双重压力。此外，长风药业此前冲击科创板时披露的千万级“医院拜访费”争议，也为其长期发展带来投资者信任与可持续性的双重考验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510083528701427.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"aad3debf34e59353425f33727c1c39c4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510083528701427.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02652"],"gpt_icon":1},{"id":"2573591950","title":"200億，中國藥谷又跑出一個IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2573591950","media":"融中财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573591950?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 11:39","pubTimestamp":1759894797,"startTime":"0","endTime":"0","summary":"此次长风药业成功IPO，不仅是一家创新药企成长的里程碑，更令苏州生物医药“IPO军团”再添一员。两位美籍博士带队，靠卖哮喘药干出一个IPO闯关IPO这一路，长风医药走得一波三折。其核心产品CF017是中国销量最高的吸入药物类别。2021年5月获批后，迅速纳入国家集采，凭借“价格优势+疗效稳定”快速放量，长风药业的市场推广体系使CF017成功覆盖了中国超过一万家医疗机构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008115536a6b05b6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008115536a6b05b6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","06978","BK1515","02652","BK1161","BK1574"],"gpt_icon":1},{"id":"2573915516","title":"開盤暴漲225%！長風藥業正式登陸港交所，吸入製劑龍頭，國產替代疊加需求爆發","url":"https://stock-news.laohu8.com/highlight/detail?id=2573915516","media":"独角兽早知道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573915516?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 10:37","pubTimestamp":1759891066,"startTime":"0","endTime":"0","summary":"数据显示，截至2日中午，长风药业获券商借出至少3396亿港元孖展，以公开发售起初集资额6077万港元计，超购5587倍。今日开盘，长风药业涨224.75%，报47.90港元/股，市值197.34亿港元。由于哮喘、COPD及过敏性鼻炎等呼吸系统疾病患病率不断上升，全球呼吸系统药物市场巨大。据估计，目前全球有将近25亿人患有慢性呼吸系统疾病，预计该数字日后还会增加。自2021年5月获批以来，长风药业的市场推广体系使CF017成功覆盖了中国超过一万家医疗机构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008104002a456ad13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"fd74786560e60f1594c09c1229106e63","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008104002a456ad13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02543","02652"],"gpt_icon":1},{"id":"2573691559","title":"勇敢者遊戲：超5000倍認購的藥企IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2573691559","media":"生物制药小编","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573691559?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 10:20","pubTimestamp":1759890055,"startTime":"0","endTime":"0","summary":"港股2025年公开发售（散户盘）的超额认购倍数最高的药企，诞生了。2025年10月3日，多家媒体报道，在港股拟IPO的药企长风药业，获得5587倍的超额认购。这个数字超过了此前银诺医药的5341倍，成为今年在港交所上市的药企中的人气之王。目前，长风药业有三款已上市药物，全部为仿制药。为何可以收获超5000倍的认购？这是一场勇敢者的游戏。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008103343a456aba1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008103343a456aba1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":1},{"id":"2573791551","title":"好買股權母基金被投企業「長風藥業」上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2573791551","media":"好买财富","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573791551?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 10:02","pubTimestamp":1759888938,"startTime":"0","endTime":"0","summary":"好买说10月8日，长风药业在港交所主板成功挂牌上市，股票代码为02652.HK，本次全球发售4119.8万股，发售价格为每股14.75港元。长风药业是好买股权母基金的被投企业。2025年1月，公司的COPD领域新产品富马酸福莫特罗吸入溶液获得国家药品监督管理局的批准上市。重要声明本文件中的信息基于已公开的信息、数据及尽调访谈等，好买财富对这些信息的及时性、准确性及完整性不做任何保证，也不保证所包含的信息不会发生变更。本文件版权为本公司所有。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008102307a6b04899&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008102307a6b04899&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":1},{"id":"2573913350","title":"招銀國際作為聯席保薦人兼整體協調人、聯席全球協調人助力長風藥業股份有限公司（長風藥業）在香港聯交所主板完成上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2573913350","media":"招银国际","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573913350?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 09:45","pubTimestamp":1759887943,"startTime":"0","endTime":"0","summary":"招银国际担任长风药业香港上市的联席保荐人兼整体协调人、联席全球协调人、联席账簿管理人2025年10月8日，长风药业股份有限公司成功于香港联交所主板挂牌上市。招银国际担任长风药业香港上市的联席保荐人兼整体协调人、联席全球协调人、联席账簿管理人,长风药业此次全球发行41,198,000 股H股，占发行后总股本的10%，发行价格为每股H股14.75港元，总发行规模约6.1亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008095835a456a321&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008095835a456a321&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":1},{"id":"1199870747","title":"異動解讀 | 長風藥業上市首日盤中大漲218.64%，超高認購率反映市場熱捧","url":"https://stock-news.laohu8.com/highlight/detail?id=1199870747","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199870747?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 09:32","pubTimestamp":1759887163,"startTime":"0","endTime":"0","summary":"长风药业今日在港交所挂牌上市，股价表现亮眼，盘中大涨218.64%，引发市场广泛关注。该公司专注于呼吸系统疾病治疗领域，此次上市反映了投资者对其业务前景的看好。根据公告，长风药业的发售价定为每股14.75港元。上市首日开盘价报47港元，较发售价大幅上涨218.64%。据悉，CF017在2024年占中国布地奈德吸入药物市场约16%的份额。长风药业此次上市融资净额约5.25亿港元，将主要用于产品研发、生产设施扩张及升级等方面，以支持公司未来发展。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"817803f49aa9435c21f99f0f245d4c72","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02652"],"gpt_icon":1},{"id":"1153529944","title":"異動解讀 | 長風藥業上市首日股價暴漲218.64%，吸入技術龍頭備受追捧","url":"https://stock-news.laohu8.com/highlight/detail?id=1153529944","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153529944?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 09:32","pubTimestamp":1759887162,"startTime":"0","endTime":"0","summary":"长风药业今日在港交所挂牌上市，股价表现强劲，盘中大涨218.64%。开盘报47港元，较发行价14.75港元大幅上涨32.25港元，成交额达2.71亿港元。不计手续费，每手500股账面获利16,125港元。长风药业此次IPO备受投资者青睐。长风药业主要专注于吸入技术及吸入药物的研发、生产及商业化，尤其针对呼吸系统疾病治疗。根据行业数据，CF017在2024年占中国布地奈德吸入药物市场约16%的份额。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"817803f49aa9435c21f99f0f245d4c72","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02652"],"gpt_icon":1},{"id":"1114810947","title":"新股首日｜長風藥業首掛高開逾218%，中籤一手賺超16000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114810947","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114810947?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 09:24","pubTimestamp":1759886689,"startTime":"0","endTime":"0","summary":"10月8日，$长风药业(02652)$上市首日大幅高开逾218%，股价报47港元；不计手续费，中签一手赚超16000港元；此前公开发售阶段获近6700倍认购，一手中签率1%。","market":"hk","thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"817803f49aa9435c21f99f0f245d4c72","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"新股首日｜长风药业首挂高开逾218%，中签一手赚超16000港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":57,"code":"91000000","status":"200"}]}}